Aris Angelis

11PUBLICATIONS
2CO-AUTHORS
Econometric and statistical methodsMajor global burdens of diseaseMedical biotechnology diagnostics (incl. biosensors)Economic models and forecastingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 10, 2025
Composite endpoints in health technology assessment: Part 2 - expanding the evidence base with a framework for best modeling practice.

Andrew Briggs, Jieling Chen, David Booth

|Sep 10, 2025
Composite endpoints in health technology assessment: Part 1 - an illustration of best modeling practice.

Andrew Briggs, Aris Angelis, Jieling Chen

|Sep 06, 2022
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.

A Angelis, J E Mellerio, P Kanavos

|Feb 21, 2022
Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.

Aris Angelis

|Sep 22, 2020
Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies.

Aris Angelis, Huseyin Naci, Allan Hackshaw

|Aug 27, 2020
Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.

Aris Angelis, Mark Thursz, Vlad Ratziu

Pageof 2

Frequent Collaborators

3 joint publications

Andrew Briggs

2 joint publications

Pardeep S Jhund